litlas
Log inCreate account

Péter Ferenci

Active 1983–2025

Also published as
Peter Ferenci
138
Papers
31,993
Citations
93
h-index
137
i10-index

Citations

Citations per year for Péter Ferenci1984: 1 citations1985: 1 citations1986: 1 citations1987: 3 citations1988: 5 citations1989: 6 citations1990: 11 citations1991: 13 citations1992: 15 citations1993: 11 citations1994: 11 citations1995: 12 citations1996: 12 citations1997: 33 citations1998: 32 citations1999: 35 citations2000: 62 citations2001: 46 citations2002: 80 citations2003: 98 citations2004: 90 citations2005: 108 citations2006: 116 citations2007: 190 citations2008: 150 citations2009: 129 citations2010: 177 citations2011: 195 citations2012: 251 citations2013: 250 citations2014: 293 citations2015: 260 citations2016: 209 citations2017: 217 citations2018: 173 citations2019: 687 citations2020: 586 citations2021: 589 citations2022: 533 citations2023: 397 citations2024: 533 citations2025: 248 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,688 citing papers, 20.5% of this breakdownGermany: 584 citing papers, 7.1% of this breakdownChina: 571 citing papers, 6.9% of this breakdownItaly: 533 citing papers, 6.5% of this breakdownUnited Kingdom: 481 citing papers, 5.8% of this breakdownFrance: 390 citing papers, 4.7% of this breakdownSpain: 387 citing papers, 4.7% of this breakdownCanada: 337 citing papers, 4.1% of this breakdownAustria: 253 citing papers, 3.1% of this breakdownJapan: 224 citing papers, 2.7% of this breakdownIndia: 218 citing papers, 2.7% of this breakdownAustralia: 186 citing papers, 2.3% of this breakdown
0%20.5%Other 28.9%

Institutions

Fields

  • Medicine76.8%
  • Nursing12.6%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Pharmacology, Toxicology and Pharmaceutics1.5%
  • Neuroscience1.1%
  • Agricultural and Biological Sciences0.5%
  • Other2.6%

Topics

  • Liver Disease Diagnosis and Treatment13.1%
  • Hepatitis C virus research10.2%
  • Liver Disease and Transplantation10.1%
  • Hepatitis B Virus Studies5.6%
  • Trace Elements in Health4.4%
  • Organ Transplantation Techniques and Outcomes3.4%
  • Other53.2%

Coauthors

All papers

Open in search
  1. Wilson disease

    Authors: Anna Członkowska, Tomasz Litwin, Petr Dušek, Péter Ferenci, Svetlana Lutsenko, Valentina Medici, Janusz Rybakowski, Karl Heinz Weiss, Michael L. Schilsky - Nature Reviews Disease Primers 2018 cited by 886

  2. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

    Authors: Hendrik Vilstrup, Piero Amodio, Jasmohan S. Bajaj, Juan Córdoba, Péter Ferenci, Kevin D. Mullen, Karin Weißenborn, Philip Wong - Hepatology 2014 cited by 2,047

  3. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

    Authors: Katharina Staufer, Ursula Huber-Schönauer, Georg Strebinger, Philipp Pimingstorfer, Silke Suesse, Thomas–Matthias Scherzer, Bernhard Paulweber, Péter Ferenci, Thomas Stimpfl, Michel Yegles, Christian Datz, Michael Trauner - Journal of Hepatology 2022 cited by 179

  4. Diagnosis and phenotypic classification of Wilson disease1

    Authors: Péter Ferenci, Karel Caca, Georgios Loudianos, Giorgina Mieli‐Vergani, Stuart Tanner, Irmin Sternlieb, Michael L. Schilsky, Diane W. Cox, Frieder Berr - Liver International 2003 cited by 921

  5. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

    Authors: Georg Semmler, Elias Laurin Meyer, K Kozbial, Philipp Schwabl, Stefanie Hametner‐Schreil, Alberto Zanetto, David Bauer, David Chromy, Benedikt Simbrunner, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, R Schöfl, Francesco Paolo Russo, Helena Greenfield, Michael Schwarz, Caroline Schwarz, Michael Gschwantler, Sonia Alonso López, María Luisa Manzano, Adriana Ahumada, Rafael Bañares, Mònica Pons, Sergio Rodríguez‐Tajes, Joan Genescà, Sabela Lens, Michael Trauner, Péter Ferenci, Thomas Reiberger, Mattias Mandorfer - Journal of Hepatology 2021 cited by 133

  6. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

    Authors: Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska, Péter Ferenci, Jeff M. Bronstein, Danny Bega, Aftab Ala, David Nicholl, Susan Flint, Lars Olsson, Thomas Plitz, Carl Bjartmar, Michael L. Schilsky - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 169

  7. Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

    Authors: Péter Ferenci, Alan H. Lockwood, Kevin D. Mullen, Ralph E. Tarter, Karin Weißenborn, Andrés T. Blei - Hepatology 2002 cited by 2,033

  8. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

    Authors: Mattias Mandorfer, K Kozbial, Philipp Schwabl, C Freissmuth, Rémy Schwarzer, R Stern, David Chromy, Albert Friedrich Stättermayer, Thomas Reiberger, S. Beinhardt, Wolfgang Sieghart, Michael Trauner, Harald Hofer, Arnulf Ferlitsch, Péter Ferenci, Markus Peck‐Radosavljevic - Journal of Hepatology 2016 cited by 301

  9. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

    Authors: Mattias Mandorfer, K Kozbial, Philipp Schwabl, David Chromy, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Virginia Hernández–Gea, Monika Fritzer‐Szekeres, Petra Steindl‐Munda, Michael Trauner, Markus Peck‐Radosavljevic, Juan Carlos García‐Pagán, Péter Ferenci, Thomas Reiberger - Hepatology 2019 cited by 160

  10. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study

    Authors: Uta Merle, Mark Schaefer, Péter Ferenci, Wolfgang Stremmel - Gut 2006 cited by 624

  11. World Gastroenterology Organisation Global Guidelines

    Authors: Douglas R. LaBrecque, Zaigham Abbas, Frank A. Anania, Péter Ferenci, Aamir Khan, Khean‐Lee Goh, Saeed Hamid, Isakov Va, Maribel Lizarzábal, Manuel M. Peñaranda, Juan Francisco Rivera Ramos, Shiv Kumar Sarin, Davor Štimac, A. B. R. Thomson, Muhammed Umar, Justus Krabshuis, Anton LeMair - Journal of Clinical Gastroenterology 2014 cited by 521

  12. Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort

    Authors: S. Beinhardt, Waltraud Leiss, Albert Friedrich Stättermayer, Ivo Graziadei, Heinz Zoller, Rudolf Stauber, A Maieron, Christian Datz, Petra Steindl‐Munda, Harald Hofer, Wolfgang Vogel, Michael Trauner, Péter Ferenci - Clinical Gastroenterology and Hepatology 2013 cited by 188

  13. Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease

    Authors: Péter Ferenci, Wolfgang Stremmel, Anna Członkowska, Ferenç Szalay, André Viveiros, Albert Friedrich Stättermayer, Radan Brůha, Roderick H.J. Houwen, Tudor Lucian Pop, Rudolf Stauber, Michael Gschwantler, Jan Pfeiffenberger, Cihan Yurdaydın, Elmar Aigner, Petra Steindl‐Munda, Hans‐Peter Dienes, Heinz Zoller, Karl Heinz Weiss - Hepatology 2018 cited by 185

  14. MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective

    Authors: Yasser Fouad, Jeffrey V. Lazarus, Francesco Negro, Markus Peck‐Radosavljevic, Shiv Kumar Sarin, Péter Ferenci, Gamal Esmat, Hasmik Ghazinian, Atsushi Nakajima, Marcelo Silva, Samuel Lee, Massimo Colombo - Alimentary Pharmacology & Therapeutics 2021 cited by 45

  15. Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease

    Authors: Karl Heinz Weiss, Florentine F. Thurik, Daniel Gotthardt, Mark A. Schafer, Ulrike Teufel, Franziska Wiegand, Uta Merle, Daniela Ferenci–Foerster, A Maieron, Rudolf Stauber, Heinz Zoller, Hartmut Schmidt, Ulrike Reuner, Harald Hefter, Jean Marc Trocello, Roderick H.J. Houwen, Péter Ferenci, Wolfgang Stremmel - Clinical Gastroenterology and Hepatology 2013 cited by 249

  16. Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study

    Authors: Mathias Jachs, Caroline Schwarz, Marlene Panzer, Teresa Binter, Stephan W. Aberle, Lukas Hartl, K Dax, Elmar Aigner, Albert Friedrich Stättermayer, Petra Munda, Ivo Graziadei, Heidemarie Holzmann, Michael Trauner, Heinz Zoller, Michael Gschwantler, Mattias Mandorfer, Thomas Reiberger, Péter Ferenci - Alimentary Pharmacology & Therapeutics 2022 cited by 74

  17. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults

    Authors: Albert Friedrich Stättermayer, Emina Halilbasic, Fritz Wrba, Péter Ferenci, Michael Trauner - Journal of Hepatology 2020 cited by 109

  18. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease

    Authors: Rafael Paternostro, Katharina Staufer, Stefan Traussnigg, Albert Friedrich Stättermayer, Emina Halilbasic, Omar Keritam, Elias Laurin Meyer, Judith Stift, Fritz Wrba, Bence Sipos, Ali Canbay, Martin Schlattjan, Elmar Aigner, Christian Datz, Felix Stickel, Clemens Schafmayer, Jochen Hampe, Stephan Buch, Gerhard Prager, Petra Munda, Mattias Mandorfer, Péter Ferenci, Michael Trauner - Hepatology International 2021 cited by 36

  19. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing

    Authors: Péter Ferenci - Human Genetics 2006 cited by 266

  20. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

    Authors: Mathias Jachs, Marlene Panzer, Lukas Hartl, Michael Schwarz, Lorenz Balcar, Jeremy V. Camp, Petra Munda, Mattias Mandorfer, Michael Trauner, Stephan W. Aberle, Heinz Zoller, Thomas Reiberger, Péter Ferenci - JHEP Reports 2023 cited by 27

  21. ESPEN Guidelines on Enteral Nutrition: Liver disease

    Authors: Mathias Plauth, Eduard Cabré, Oliviero Riggio, M. Assis-Camilo, Matthias Pirlich, Jens Kondrup, Péter Ferenci, E. Holm, S. vom Dahl, Manfred J. Müller, W. Nolte - Clinical Nutrition 2006 cited by 683

  22. Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network (HDIN)

    Authors: Anika Wranke, Lourdes Maria Pinheiro Borzacov, Raymundo Paraná, Cirley Lobato, Saeed Hamid, Emanoil Ceaușu, George Ν. Dalekos, Mario Rizzetto, Adela Turcanu, Grazia Anna Niro, Farheen Lubna, Minaam Abbas, Patrick Ingiliz, Marı́a Buti, Péter Ferenci, Thomas Vanwolleghem, Tonya Hayden, Naranjargal Dashdorj, Adriana Moţoc, Markus Cornberg, Zaigham Abbas, Cihan Yurdaydın, Michael P. Manns, Heiner Wedemeyer, Svenja Hardtke, the Hepatitis Delta International Network - Liver International 2017 cited by 91

  23. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

    Authors: Georg Semmler, Teresa Binter, K Kozbial, Philipp Schwabl, Stefanie Hametner‐Schreil, Alberto Zanetto, Sabrina Gavasso, David Chromy, David Bauer, Benedikt Simbrunner, Bernhard Scheiner, Theresa Bucsics, Albert Friedrich Stättermayer, Matthias Pinter, Petra Steindl‐Munda, R Schöfl, Francesco Paolo Russo, Paolo Simioni, Michael Trauner, Péter Ferenci, Thomas Reiberger, Mattias Mandorfer - Hepatology 2020 cited by 74

  24. Partial pressure of ammonia versus ammonia in hepatic encephalopathy

    Authors: Ludwig Kramer, Barbara Tribl, Alexandra Gendo, Christian Zauner, Barbara Schneider, Péter Ferenci, Christian Madl - Hepatology 2000 cited by 168